P
Paxlovid
Productby Pfizer
Heard in 5 episodes across 5 shows since Sep 2026
An oral antiviral treatment combining nirmatrelvir and ritonavir to reduce the risk of severe COVID-19 in eligible patients.
Episodes
5
across 5 shows
First heard
Sep 2026
Expert statements
1
1 positive
Episodes per month
Public PodLume episodes featuring it, over the last year.
2
1
2
Show the data
| Month | Episodes |
|---|---|
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 2 |
| Oct 2026 | 1 |
| Nov 2026 | 2 |
Email alert
Email me when Paxlovid comes up on a podcast
One email a week at most, with the new episodes that mention Paxlovid. Free, no account needed, unsubscribe in one click.
What experts have said about Paxlovid
1 statement · 1 positive
Paxlovid reduced COVID-19 hospitalization and death in large randomized trials.
“the large randomized trials, there was a reduction in hospitalization and death.”
Open the episode · #2576 - Dr. Peter McCulloughListen at 1:08:43
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
5 episodes featuring Paxlovid, newest first
- Nov 4, 2026
McCullough challenges pandemic orthodoxy and institutional trustThe Joe Rogan ExperienceNov 4, 2026 - Nov 2, 2026
Amy Burroughs turned biotech uncertainty into negotiating powerTiger SistersNov 2, 2026 - Oct 29, 2026
Whoop bets continuous health data can outpace traditional testingAll-In with Chamath, Jason, Sacks & FriedbergOct 29, 2026 - Sep 8, 2026
Horowitz links chronic inflammation to cognitive declineThe Ultimate Human with Gary BreckaSep 8, 2026 - Sep 4, 2026
Dr Mark Hyman outlines how data-driven testing is reforming patient careThis Week in StartupsSep 4, 2026